Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials.

MLA

Rindone, Joseph P., and Chadwick K. Mellen. “Sacubitril/Valsartan Compared to Equivalent/Sub-Equivalent Dose Angiotensin Receptor Blocker or Angiotensin-Converting Enzyme Inhibitor in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Randomized Trials.” European Journal of Clinical Pharmacology, vol. 80, no. 8, Aug. 2024, pp. 1113–20. EBSCOhost, https://doi.org/10.1007/s00228-024-03686-6.

APA

Rindone, J. P., & Mellen, C. K. (2024). Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials. European Journal of Clinical Pharmacology, 80(8), 1113–1120. https://doi.org/10.1007/s00228-024-03686-6

Chicago

Rindone, Joseph P, and Chadwick K Mellen. 2024. “Sacubitril/Valsartan Compared to Equivalent/Sub-Equivalent Dose Angiotensin Receptor Blocker or Angiotensin-Converting Enzyme Inhibitor in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Randomized Trials.” European Journal of Clinical Pharmacology 80 (8): 1113–20. doi:10.1007/s00228-024-03686-6.